Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £15.07m
SYS Live PriceLast checked at - London Stock Exchange

Intraday Sysgroup Share Chart

System C Medway Go Live

13 Oct 2010 09:32

RNS Number : 3041U
System C Healthcare plc
13 October 2010
 



13 October 2010

 

System C Healthcare PLC

("System C" or the "Company")

 

System C makes gains in the independent treatment centre market.

 

System C is pleased to announce that Care UK Ltd ("Care UK"), the independent healthcare provider, has gone live with the Medway PAS/EPR at six recently-acquired treatment centres. The deployments were successfully completed in a tight timeframe, with the final go-live being implemented in less than a month.

 

The move has consolidated System C's position in the NHS independent treatment centre market. In addition to Care UK, the Company has contracts with Nations Healthcare and Circle Health.

 

Independent treatment centres have been established to provide fast, same day or short-stay surgery and diagnostic procedures, traditionally in areas that have the longest waiting times within the NHS. Patients treated at an NHS Treatment Centre which is managed by an independent healthcare company are still NHS patients.

 

Care UK set out to replace legacy IT systems in its six newly-acquired centres with a proven solution that was Choose & Book compliant. Care UK treats over 37,000 patients a year and claims to be the country's largest operator of NHS independent treatment centres.

 

Medway Proxima, a version of System C's Medway PAS/EPR designed specifically for the independent healthcare market, was selected on the strength of its performance and track record.

 

System C completed the first phase of the PAS replacement programme between May 2009 and January 2010. As well as delivering enhanced patient, referral and scheduling capabilities, Medway provided the sites with direct booking of their services using Choose & Book. Since then, phase 2 has been completed in a staged process, with each facility going live with full Medway, including patient tracking, clinical records, resource management and electronic discharge notifications.

 

"As one of the UK's leading providers of elective surgery on behalf of the NHS, Care UK uses Choose & Book to promote its services to GPs, to provide information to patients and to enable them to make bookings", said Jardine Barrington-Cook, Care UK's head of business systems, healthcare.

 

Dr Ian Denley, chief executive at System C, commented: "This was a rapid and high pressure deployment and we are delighted that it has been so successful."

 

 

For further information, contact:

 

System C Healthcare plc

Tel: 01622 691 616

Dr Ian Denley, Chief Executive

Charles Stanley Securities

Tel: 020 7149 6000

Nominated Adviser

Russell Cook / Mark Taylor

Maitland

Tel: 020 7379 5151

Financial PR

Emma Burdett / Richard Farnsworth

 

 

Notes to editors:

 

System C Healthcare plc (www.systemc.com), specialises in the design and development of clinical patient management and business intelligence software, and provides systems implementation and consulting services to the health and social care sectors.

 

The Medway PAS/EPR is a family of products, built specifically for the UK health sector, which covers all aspects of patient management and care. The products can be deployed as stand-alone modules or be integrated with third party and other Medway clinical systems. Medway is today used in over 40 NHS Trusts.

 

System C (SYS:L) is quoted on the AIM Market of London Stock Exchange.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAKKNDNFBDKDKD
Date   Source Headline
19th May 20267:00 amRNSChange of Registered Office
13th Apr 20267:00 amRNSYear End Trading Update
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
9th Feb 202610:15 amRNS-RIT Infrastructure Refresh Contract Win
3rd Feb 20264:13 pmRNSDirector/PDMR Dealing
29th Jan 20262:11 pmRNS-RContract win with the Scouts Association
22nd Jan 20269:34 amRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
9th Dec 202512:06 pmRNS-RAppointment of AI Adviser
3rd Dec 20257:00 amRNSHalf Year Results to 30 September 2025
25th Nov 20257:00 amRNSNotice of Results
16th Sep 20253:38 pmRNSResult of AGM
12th Sep 202510:51 amRNSDirector Dealing
8th Sep 202512:17 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20257:00 amRNSGrant of Options and PDMR Dealings
8th Aug 20257:00 amRNSNotice of AGM and Publication of Accounts
29th Jul 202510:17 amRNSDirector/PDMR Dealing
24th Jul 20257:00 amRNSFinal Results for the year ended 31 March 2025
14th Jul 20257:00 amRNSNotice of Results
29th Apr 20257:00 amRNSYear End Trading Update
20th Mar 202511:34 amRNS-RSysGroup Joins Rubrik's Advanced Partner Program
29th Jan 20259:17 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirector/PDMR Dealing
22nd Jan 20257:00 amRNSHolding(s) in Company
19th Dec 202412:45 pmRNSExercise of Options and Total Voting Rights
4th Dec 20244:00 pmRNSPresentation via Investor Meet Company
3rd Dec 20241:00 pmRNSDirector/PDMR Dealing
3rd Dec 20247:00 amRNSHalf Year Results to 30 September 2024
19th Nov 20247:00 amRNSAcquisition & Notice of Results
20th Sep 202411:00 amRNSResult of AGM
12th Sep 20247:00 amRNSAIM Rule 17 and Schedule 2(g) Disclosure
3rd Sep 20247:00 amRNSGrant of Options and Director/PDMR Dealings
21st Aug 20244:50 pmRNSGrant of Options and Director/PDMR Dealings
15th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
31st Jul 20247:00 amRNSFinal Results for the year ended 31 March 2024
24th Jul 20247:00 amRNSNotice of Results
28th Jun 202410:10 amRNSHolding(s) in Company
28th Jun 20247:00 amRNSHolding(s) in Company
24th Jun 20244:12 pmRNSResult of General Meeting and Total Voting Rights
14th Jun 20247:00 amRNSResult of Retail Offer
7th Jun 20248:00 amRNSLaunch of Retail Offer
7th Jun 20247:00 amRNSResult of Oversubscribed Placing and Subscription
6th Jun 20245:11 pmRNSProposed Fundraising
3rd Jun 20247:00 amRNSBoard Changes
29th May 20247:00 amRNSStrategic Partnership
30th Apr 20247:00 amRNSTrading Update
29th Feb 20248:49 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.